Menu
Back to Journals » Cancer Management and Research » Volume 10
RETRACTED ARTICLE: Osthole sensitizes with radiotherapy to suppress tumorigenesis of human nasopharyngeal carcinoma in vitro and in vivo
Authors Peng L, Huang YT, Chen J, Zhuang YX , Zhang F, Chen JY, Zhou L, Zhang DH
Received 6 August 2018
Accepted for publication 6 October 2018
Published 8 November 2018 Volume 2018:10 Pages 5471—5477
DOI https://doi.org/10.2147/CMAR.S182798
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Ahmet Emre Eşkazan
This paper has been retracted.
Peng L, Huang YT, Chen J, et al. Cancer Manag Res. 2018;10:5471–5477.
The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised regarding the alleged duplication of flow cytometry images in Figure 3. Specifically,
- The image for Figure 3A, Ctrl, appears to have regions of unexpected duplication with the image for Figure 3A, 2 Gy.
- The image for Figure 3A, 5 Gy, appears to have regions of unexpected duplication with the image for Figure 3A, Osthole.
The authors agreed with the concerns that had been raised and provided data related to the study, however it was unable to verify the validity of the published work. Therefore, the decision was made to retract the article and the authors were notified of this.
We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.